Literature DB >> 1064592

Results of surgical treatment in 65 dogs with osteosarcoma.

R S Brodey, D A Abt.   

Abstract

Clinical and necropsy findings were obtained from case records for 65 dogs treated surgically for osteosarcoma at the University of Pennsylvania Small Animal Hospital between July, 1952, and July, 1973, inclusive. The median age of the dogs was 6 years. There were 39 males and 26 females. All but 5 of the 65 dogs weighed more than 16 kg. Sixty-two of the osteosarcomas arose from the limbs and 3 from the ribs. The median duration of presurgical clinical signs was 6 weeks, with a range of 1 day to 24 weeks. There were no statistical correlations between the postsurigical survival times and the age, sex, or breed of the dog, the site of the osteosarcoma, or the duration of the presurgical clinical signs. Of the 40 dogs with known lung metastases, 11 also had hypertrophic pulmonary osteoarthropathy. The median survival time was 18 weeks, with a range of 3 to greater than 578 weeks. Twenty-six percent were alive 6 months potoperatively, 13.8% were still alive at 9 months, and 10.7% survived more than 1 year. The total median duration of the disease was 24 weeks (range, 8 greater than 578 weeks).

Entities:  

Mesh:

Year:  1976        PMID: 1064592

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  12 in total

1.  Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway.

Authors:  Kristin P Anfinsen; Tom Grotmol; Oyvind S Bruland; Thora J Jonasdottir
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

Review 2.  Macrophages and cancer.

Authors:  P W Whitworth; C C Pak; J Esgro; E S Kleinerman; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

3.  Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival.

Authors:  Agneta Egenvall; Ane Nødtvedt; Henrik von Euler
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

Review 4.  Prognostic factors in canine appendicular osteosarcoma - a meta-analysis.

Authors:  Ilse Boerman; Gayathri T Selvarajah; Mirjam Nielen; Jolle Kirpensteijn
Journal:  BMC Vet Res       Date:  2012-05-15       Impact factor: 2.741

5.  The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma.

Authors:  R S Brodey
Journal:  Yale J Biol Med       Date:  1979 Jul-Aug

6.  The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.

Authors:  Rui Zhang; Douglas H Thamm; Vikram Misra
Journal:  BMC Vet Res       Date:  2015-02-07       Impact factor: 2.741

Review 7.  What do we know about canine osteosarcoma treatment? Review.

Authors:  M Szewczyk; R Lechowski; K Zabielska
Journal:  Vet Res Commun       Date:  2014-11-26       Impact factor: 2.459

Review 8.  The immunotherapy of canine osteosarcoma: a historical and systematic review.

Authors:  K L Wycislo; T M Fan
Journal:  J Vet Intern Med       Date:  2015-04-30       Impact factor: 3.333

9.  Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.

Authors:  Gayathri T Selvarajah; Jolle Kirpensteijn; Monique E van Wolferen; Nagesha A S Rao; Hille Fieten; Jan A Mol
Journal:  Mol Cancer       Date:  2009-09-07       Impact factor: 27.401

10.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.